Roivant Sciences Ltd., 10% Owner at Immunovant, Inc. (IMVT), bought 416,667 shares at $6.00 ($2.5M) on 2022-10-06, disclosed to the SEC on 2022-10-07.
Open-market purchase of $2.5M IMVT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |
| IMVT | BUY | 2020-04-17 | $30.0M | — | Filing → |